The American Transplant Congress (ATC), which takes place June 4-8, is the Joint Annual Meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST).

ATC brings together transplant physicians, researchers, nurses, organ procurement personnel, pharmacists, and other transplant professionals for a forum to exchange new scientific and clinical information relevant to solid organ and tissue transplantation. The educational offerings provide attendees the opportunity to learn cutting-edge advances in research and clinical practice, as well as to discuss socioeconomic, ethical, and regulatory issues related to solid organ and tissue transplantation.

Researchers from Baylor Scott & White Health, including Baylor University Medical Center – Dallas, will be heavily involved in this year's event with more than three dozen talks and presentations scheduled here: Baylor Scott & White presentation schedule.

A featured list of Baylor Scott & White presentations can be found below. Additional details about ATC 2022 can be found on the event website here.

 

Giuliano Testa, MD, MBA, FACS, Chief of Abdominal Transplant at Baylor University Medical Center – Dallas provides overview of Baylor Scott & White participation at the American Transplant Congress.

Highlights:

Sumeet Asrani, MD, MSc, Medical Director for the Center For Advanced Liver Disease at Baylor University Medical Center – Dallas invites you to attend his impact session: “I Don’t Want My Patients’ Kidneys To Fail!!”


Liza Johannesson, MD, PhD, Medical Director of Uterus Transplant at Baylor University Medical Center – Dallas gives a preview of her oral abstract: Living Donor Robotic Hysterectomy Provides Excellent Outcomes in Uterus Transplant Recipients

 

 

 

Featured Presentations

For the FULL schedule of the more than 35 presentations and sessions highlighting Baylor Scott & White’s Transplant Research Click Here.

 

Poster Abstract: A Successful Expansion of Donor Liver Supply Is Feasible With the Selective Use of Older DCD Livers

  • Author:  Greg McKenna, MD, FRSC(C), FACS

  • Time/Location: JUNE 4, 5:30 PM - 7:00 PM EST - Hynes Halls C & D

  • Abstract/Study Purpose:  DCD are a key way to expand the donor pool, yet many centers are hesitant about using anything but the most favorable DCD allografts, given the lack of data regarding older donors. Expanding to older DCD donors >50 years may be an untapped potential option to increase donor liver supply.

  • For More Information:  Click Here

  • Video Abstract:  Click Here


Poster Abstract: An In Depth Assessment of Unsuccessful DCD Donor Procurement Attempts: Areas for Improvement

  • Author:  Greg McKenna, MD, FRSC(C), FACS

  • Time/Location:  JUNE 4, 5:30 PM - 7:00 PM EST - Hynes Halls C & D

  • Abstract/Study Purpose:  DCD donors are a key way to expand allograft supply but an aggressive strategy of pursuing DCD liver allografts is associated with significant number of unsuccessful donor procurements. Understanding the elements in unsuccessful DCD can allow more efficient decisions, and maximize DCD procurements.

  • For More Information:  Click Here

  • Video Abstract:  Click Here


Poster Abstract: Increased Use of DCD Liver Grafts Does Not Adversely Affect Outcomes: A Single-center Experience

  • Presenter:  Michele Finotti, MD

  • Time/Location:  JUNE 4, 5:30 PM - 7:00 PM EST - Hynes Halls C & D

  • Abstract/Study Purpose:  Donation after circulatory death (DCD) donors are underutilized in liver transplantation (LT), partly due to fear of inferior outcomes. Our center has evolved from a low- to high-DCD liver utilization program. We hypothesized that there would be a difference in donor and recipient characteristics as well as recipient outcomes between high and low DCD utilization eras.

  • For More Information:  Click Here

  • Video Abstract:  Click Here


Poster Abstract: Does ABO/HLA Matching Matter In Uterus Transplantation

  • Author:  Liza Johannesson, MD, PhD

  • Time/Location: JUNE 5, 7:00 PM - 8:00 PM EST – Hynes Hall C & D

  • Abstract/Study Purpose: Uterus transplantation (UTx) is the most commonly performed vascular composite allograft and is rapidly becoming an accepted treatment for absolute uterine-factor infertility (AUFI). There is little known of how ABO/HLA -donor/recipient compatibility affects UTx transplant outcome. This study aimed to assess the importance of ABO/HLA-donor/recipient compatibility in relation to rejection, graft survival and live birth rate.

  • For More Information: Click Here

  • Video Abstract:  Click Here


Poster Abstract: Variation Exists In Hospital Policies for Donation after Circulatory Death within a Single Donor Service Area

  • Author:  Rehma Shabbir

  • Time/Location: JUNE 6, 7:00 PM - 8:00 PM EST - Hynes Halls C & D

  • Abstract/Study Purpose: The Joint Commission mandates that all hospitals have a donation after circulatory death (DCD) policy. Previous studies have demonstrated variability in DCD policy elements. With the increasing utilization of DCD donors, we hypothesized that there would be more consistency among DCD policies.

  • For More Information: Click Here

  • Video Abstract:  Click Here


Oral Abstract: Donors’ Perceptions of Uterus Donation Motivations, Informed Consent and Value: A Qualitative Study Of Dallas Uterus Transplant Study (DUETS) Participants

  • Author: Anji Wall, MD, PhD

  • Time/Location:  JUNE 7, 4:10 PM EST - Hynes Room 313

  • Abstract/Study Purpose: Clinical trials have demonstrated the feasibility and reproducibility of uterus transplantation (UTx) to treat absolute uterine factor infertility. Successful live births have resulted from both deceased and living donor uterus transplantation, with more successful recipient pregnancies after living uterus donation. The utilization of living uterus donors for this quality of life-enhancing transplantation remain controversial because of the risks that living uterus donation entails. This study aimed to assess the perceptions of living uterus donors regarding their motivations for donation, perceptions of informed consent, and the value of the uterus donation experience.

  • For More Information: Click Here

  • Video Abstract:  Click Here


Oral Abstract: Living Donor Robotic Hysterectomy Provides Excellent Outcomes in Uterus Transplant Recipients

  • Author: Liza Johannesson, MD, PhD

  • Time/Location:  JUNE 7, 4:50 PM EST - Hynes Room 313

  • Abstract/Study Purpose: Living donor (LD) hysterectomy for Uterus Transplantation (UTx) can be performed robotically with vaginal extraction of the graft. There are no reports of the technical or functional outcomes of robotically procured grafts (RPG). This study reports outcomes from the largest series of UTx performed with RPG.

  • For More Information: Click Here

  • Video Abstract:  Click Here


Plenary Session: A Single Center Analysis of Organ Offers and Workload for Liver and Kidney Allocation

  • Author:  Vik Reddy

  • Time/Location: JUNE8, 8:30 AM EST - Hynes Veterans Auditorium

  • Abstract/Study Purpose: UNOS/OPTN transitioned to Acuity Circles allocation for kidneys and livers which has increased the complexity of the network of organ procurement organizations (OPOs) and transplant centers. Moreover, there is increased pressure on OPOs to allocate organs. In this study, we hypothesized that allocation changes and regulatory pressure have increased organ offers and program workload.

  • For More Information: Click Here

  • Video Abstract:  Click Here